SCHEMBL29633009

SCHEMBL29633009

CCCCCCCCCCCCCCCc1cccc(O)c1C(=O)c1cc(OC)c(OC)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 6/20 0.59
MCL1 Q07820 6/20 0.59
BCL2L1 Q07817 5/20 0.59
BAK1 Q16611 5/20 0.59
KAT8 Q9H7Z6 3/20 0.59
PPARA Q07869 3/20 0.59
SAE1 Q9UBE0 2/20 0.59
EP300 Q09472 2/20 0.59
KAT5 Q92993 2/20 0.59
PPARG P37231 2/20 0.59
KAT2A Q92830 1/20 0.59
KAT2B Q92831 1/20 0.59
F7 P08709 3/20 0.52
F3 P13726 3/20 0.52
MMP2 P08253 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
ALOX15 P16050 1/20 0.52
ECE1 P42892 1/20 0.52
SGMS1 Q86VZ5 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31220510 0.93 BID (0.59) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL29633047 0.87 BID (0.55) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL31220651 0.82 BID (0.57) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL28931275 0.82 BID (0.71) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL29633018 0.82 PPARA (0.57) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL28665894 0.82 PPARA (0.57) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL5551371 0.81 PPARA (0.69) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL4292268 0.77 BID (0.76) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL17725664 0.77 BID (0.71) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL11150170 0.76 BID (0.69) BIDMCL1BCL2L1BAK1KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275711-B2 Compounds having excited state intramolecular proton transfer (ESIPT) character for use in treating and/or preventing sunburn and/or preventing U.V. damage UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) 2025-04-15 US disclosed
CN-113692403-B Compounds having excited state intramolecular proton transfer (esit) properties for use in the treatment and/or prevention of sunburn and/or prevention of u.v. damage 约翰内斯堡威特沃特斯兰德大学 2024-11-22 CN disclosed
US-20220144785-A1 COMPOUNDS HAVING EXCITED STATE INTRAMOLECULAR PROTON TRANSFER (ESIPT) CHARACTER FOR USE IN TREATING AND/OR PREVENTING SUNBURN AND/OR PREVENTING U.V. DAMAGE UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12275711-B2 Compounds having excited state intramolecular proton transfer (ESIPT) character for use in treating and/or preventing sunburn and/or preventing U.V. damage NNT, NQO1, SUN2 BID 1555/4885MCL1 4143/4885BCL2L1 538/4885
US-20220144785-A1 COMPOUNDS HAVING EXCITED STATE INTRAMOLECULAR PROTON TRANSFER (ESIPT) CHARACTER FOR USE IN TREATING AND/OR PREVENTING SUNBURN AND/OR PREVENTING U.V. DAMAGE NNT, NQO1, SUN2 BID 1555/4885MCL1 4143/4885BCL2L1 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.